SCHEMBL23745659

SCHEMBL23745659

Cc1cccc(C(CCN[C@H]2CC[C@H](NC(=O)OC(C)(C)C)CC2)c2cn(C3CCCCC3)c3ccc(-c4ccnn4C)cc23)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4D Q6B0I6 9/20 0.35
KMT2A Q03164 2/20 0.33
BRD4 O60885 1/20 0.33
BRD3 Q15059 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM1A O60341 1/20 0.32
KDM6A O15550 1/20 0.32
CCR5 P51681 1/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
OPRK1 P41145 1/20 0.31
OGFRL1 Q5TC84 1/20 0.31
MEN1 O00255 1/20 0.31
FAAH O00519 1/20 0.31
DRD2 P14416 1/20 0.31
DRD3 P35462 1/20 0.31
MAPK1 P28482 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23722062 0.92 CTSA (0.34) BRD4BRD3DRD2DRD3MAPK1
SCHEMBL23722049 0.87 MAPK1 (0.33) BRD4BRD3JAK1MAPK1
SCHEMBL23745353 0.87 MPO (0.33) BRD4BRD3DRD2MAPK1IRAK4
Hydrochloric Acid SCHEMBL23722089 0.86 MPO (0.32) BRD4BRD3DRD2MAPK1IRAK4
Hydrochloric Acid SCHEMBL23722103 0.86 MPO (0.32) BRD4BRD3DRD2MAPK1IRAK4
SCHEMBL23745602 0.86 NAAA (0.32) BRD4BRD3DRD2MAPK1IRAK4
SCHEMBL23722059 0.82 NAAA (0.36) KMT2ABRD4BRD3MEN1DRD2
SCHEMBL22439409 0.80 BRD4 (0.36) KMT2ABRD4BRD3MEN1DRD2
SCHEMBL23745356 0.80 CTSA (0.38) KMT2ABRD4BRD3MEN1FAAH
SCHEMBL23722113 0.79 CCR5 (0.37) KDM4DKMT2AL3MBTL1KDM1ACCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 KDM4D 4476/4885KMT2A 4684/4885BRD4 1900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.